CHJWM
ABBV icon

Carlton Hofferkamp & Jenks Wealth Management’s AbbVie ABBV Stock Holding History

Carlton Hofferkamp & Jenks Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Sell
8,845
-13
-0.1% -$2.8K 0.72% 30
2026
Q1 		$1.75M Sell
8,858
-906
-9% -$201K 0.58% 38
2025
Q4 		$2.23M Sell
9,764
-21
-0.2% -$4.78K 0.75% 33
2025
Q3 		$2.23M Sell
9,785
-226
-2% -$46K 0.75% 34
2025
Q2 		$1.9M Sell
10,011
-206
-2% -$38.3K 0.69% 34
2025
Q1 		$1.75M Sell
10,217
-116
-1% -$22.6K 0.72% 33
2024
Q4 		$1.98M Sell
10,333
-53
-0.5% -$9.74K 0.73% 32
2024
Q3 		$2.08M Sell
10,386
-205
-2% -$38.3K 0.79% 31
2024
Q2 		$1.98M Buy
10,591
+23
+0.2% +$3.81K 0.77% 33
2024
Q1 		$1.77M Buy
10,568
+43
+0.4% +$7.41K 0.74% 32
2023
Q4 		$1.73M Hold
10,525
– – 0.72% 33
2023
Q3 		$1.53M Buy
10,525
+75
+0.7% +$11K 0.71% 35
2023
Q2 		$1.54M Buy
10,450
+10
+0.1% +$1.47K 0.68% 33
2023
Q1 		$1.53M Sell
10,440
-333
-3% -$50.9K 0.7% 36
2022
Q4 		$1.58M Sell
10,773
-72
-0.7% -$11K 0.69% 36
2022
Q3 		$1.59M Sell
10,845
-65
-0.6% -$9.33K 0.75% 36
2022
Q2 		$1.67M Buy
10,910
+25
+0.2% +$3.82K 0.77% 34
2022
Q1 		$1.9M Sell
10,885
-274
-2% -$39.8K 0.78% 35
2021
Q4 		$1.49M Sell
11,159
-140
-1% -$16.5K 0.63% 44
2021
Q3 		$1.31M Buy
11,299
+471
+4% +$53.8K 0.53% 52
2021
Q2 		$1.27M Sell
10,828
-69
-0.6% -$7.77K 0.55% 50
2021
Q1 		$1.21M Buy
10,897
+875
+9% +$93.6K 0.54% 49
2020
Q4 		$1.12M Sell
10,022
-450
-4% -$43.2K 0.55% 50
2020
Q3 		$1.03M Buy
10,472
+1,967
+23% +$185K 0.54% 52
2020
Q2 		$825K Buy
8,505
+334
+4% +$29.4K 0.47% 56
2020
Q1 		$684K Buy
8,171
+1,566
+24% +$133K 0.42% 60
2019
Q4 		$555K Buy
6,605
+451
+7% +$37.4K 0.31% 71
2019
Q3 		$458K Buy
6,154
+1,500
+32% +$103K 0.28% 74
2019
Q2 		$318K Buy
4,654
+841
+22% +$66.1K 0.19% 80
2019
Q1 		$307K Buy
3,813
+786
+26% +$64.3K 0.19% 78
2018
Q4 		$279K Buy
+3,027
New +$266K 0.2% 76

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Carlton Hofferkamp & Jenks Wealth Management's ABBV Position: Q2 2026 in Review

Carlton Hofferkamp & Jenks Wealth Management reduced its AbbVie (ABBV) stake by 0.15% in Q2 2026, selling an estimated $2.8K and leaving 8,845 shares worth $2.24M. The position accounts for 0.72% of the portfolio, ranked #30.

Carlton Hofferkamp & Jenks Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Carlton Hofferkamp & Jenks Wealth Management held 8,845 shares of AbbVie worth $2.24M as of Q2 2026.
  • Carlton Hofferkamp & Jenks Wealth Management sold 13 AbbVie shares in Q2 2026, an estimated $2.8K.
  • AbbVie made up 0.72% of Carlton Hofferkamp & Jenks Wealth Management's portfolio in Q2 2026, its #30 holding.
  • Carlton Hofferkamp & Jenks Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
  • 1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Carlton Hofferkamp & Jenks Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.